Summary: Effects of nicotine treatment (4.5 mg/kg of nico tine-free base/day administered s.c. by osmotic mini pumps for 14 days) on focal ischemic stroke and expression of tissue plasminogen activator (t-PA) and plasminogen acti vator inhibitor-I (PAl-I) in cerebral microvessels were studied in rats in vivo using a reversible (I h) middle cere bral artery occlusion model. Plasma levels of nicotine and its major metabolite cotinine after 14 days of treatment were 88 and 364 ng/ml, respectively. Nicotine treatment resulted in 35-40% (p <0.001) decrease in the blood flow in the periphery of the ischemic core during reperfusion, an increase in the neurologic score of 2.6-fold (p <0.01), and 36% (p <0.05) and 121 % (p <0.01) increases in the Cigarette smoking has been accepted as a major factor that increases the risk of coronary disease, peripheral vascular disease and stroke (Gill et aI., 1989). Although epidemiological studies of smokers may not directly translate into equivalent effects of nicotine (a major constituent of cigarette smoke), few recent clinical studies have indicated that applica tion of nicotine patches alone could precipitate isch emic stroke in chronic smokers (Jackson, 1993; Pierce, 1994 
Cigarette smoking has been accepted as a major factor that increases the risk of coronary disease, peripheral vascular disease and stroke (Gill et aI., 1989) . Although epidemiological studies of smokers may not directly translate into equivalent effects of nicotine (a major constituent of cigarette smoke), few recent clinical studies have indicated that applica tion of nicotine patches alone could precipitate isch emic stroke in chronic smokers (Jackson, 1993; Pierce, 1994) . It has been suggested that smoking products and/or nicotine may predispose to cerebral thrombosis, possibly by causing an imbalance be tween brain vascular coagulation and fibrinolytic sys tems (Allen et aI., 1985; Folts, 1988; Hashimoto et aI., 1988) . Altered coagulation and abnormal fibrinolysis have been shown to be present in the blood of isch emic stroke patients (Fisher and Francis, 1990) , in cluding chronic smokers (Folts. 1988; Hashimoto et aI., 1988; Ozdemir et aI., 1992) . In spite of this, evi dence demonstrating a direct link between chronic exposure to nicotine and stroke, on the one hand, and altered brain endothelial thrombotic potential, on the other, is still limited.
Tissue plasminogen activator (t -P A) and plasmino gen activator inhibitor-l (PAl-I) play key roles in the control of fibrinolysis within the vascular system (Collen, 1980; Loskutoff et aI., 1993) . Injured or stim-, ulated endothelium releases t-PA, which preferen tially converts fibrin-bound plasminogen into plas min-an active serine protease involved in a broad spectrum of extracellular proteolytic processes, in cluding fibrinolysis and thrombolysis (van Hinsbergh et aI., 1991) . Much of t-PA in normal plasma and in tissues is inactive and complexed to PAl-I, which is considered to be a primary endogenous inhibitor of t-PA in plasma and tissues (Loskutoff et aI., 1993) . It has been suggested that t -P A and PAl -1 cxpression may vary among species and tissues, and with the type of stimulation (Emeis et aI., 1995 versus Biemond et aI., 1995 del Zoppo, 1994 versus Zlokovic et aI., 1995b; Padro et aI., 1994; Kollros et aI., 1994 versus Kittaka et aI., 1996 . Expression of t-P A and PAI-1 has been shown recently in bovine (Kollros et aI., 1994) and human (Shatos et aI., 1995) brain microvascular endothelial cells in vitro. Recently, we reported that t-PA is normally expressed in vivo in cerebral capillaries in rodents, and that both t-PA antigen and t-PA mRNA are preserved in microves sels isolated immediately ex vivo from rodent brain (Zlokovic et aI., 1995b; Zlokovic et aI., 1995a; Kittaka et aI., 1996) . In addition to proposed fibrinolytic func tion and vascular effects of t-PA (Zlokovic et aI., 1995b) , other roles for t-PA in "mature" brain in clude mediation of activity-dependent synaptic plas ticity-as, for example, during motor learning (Seeds et aI., 1995) and long-term potentiation (Qian et aI., 1994) -and a role in some types of neuronal degener ation induced by excitotoxins (Tsirka et aI., 1995) .
Nicotine ca f\ mediate t-P A release from bovine aortic endothelial cells in vitro (Kuo et aI., 1989) , and acute smoking may cause a transient increase in plasma t-PA antigen in human nonsmokers (Allen et aI., 1985) . However, in habitual smokers with chronically elevated plasma nicotine levels, both plasma t-PA activity and the fibrinolytic activity of systemic vessel walls are significantly reduced in com parison to those in nonsmokers (Allen et aI., 1985; Kjaelgaard and Larsson, 1986; Haire et aI., 1989; Ozdemir et aI., 1992) . In the present study, we used a reversible middle cerebral artery (MeA) occlu sion model in rats to examine the effects of chronic nicotine administration on focal ischemic stroke in relation to brain microvascular t-PA and PAI-1 ex pression. Preliminary results have been reported else where (Sun et aI., 1995; Zlokovic et aI., 1996) .
METHODS
Male Sprague-Dawley (Charles River Breeders, Hollis ter, CA, U.S.A.) rats weighing 260-300 g each were housed under diurnal light conditions, with unlimited access to food and water, and allowed a minimum of 3 days for acclimation. All procedures were done in accordance with the Animal Care Guidelines at the University of Southern California as approved by the National Institutes of Health.
Nicotine administration
Rats were implanted with osmotic mmlpumps (Alzet 2002, Alza Corporation, Palo Alto, CA, U.S.A.) s.c. for continuous delivery of either nicotine tartrate (n = 24) in 0.9% NaCI (4.5 mg/kg) of nicotinc-free base/day) or vehicle (n = 24) only 0.9% NaCl) for 14 days, according to pub lished procedure (Murrin et aI., 1987) . Pumps were im planted under strictly aseptic conditions. No sign of in flammation or infection was observed in the area of pump placemcnt. By comparing 14-day sham-operated animals with animals implanted with osmotic minipumps and vehi cle only, it was confirmed that the pump placement proce dure does not have any effect on the parameters in the present study including physiologic variables, blood flow and head temperature, neurologic scores, or neuropatho logic outcome in a model of reversible MCA occlusion.
Pump placement does not affect the expression of several antigens in brain including ai, 0'2, 0'3,131 and f32 subunits of the sodium pump and y-glutamyl-transpeptidase (Wang et aI. , 1994) and the t-PA in the present study. Levels of nicotinc and its major metabolite cotinine were determined in plasma (Haley et aI. , 1983) .
Focal ischemia study
Rats were deprived of food for 12 h prior to surgery.
Reversible MCA occlusion was performed in nicotine treated (n = 12) and control (n = 12) rats using an intralum inal thread technique (Zea Longa et aI. , 1989) , as recently modified in our laboratory (Kittaka et aI., 1996) . The proce dure involved initial anesthesia with metofane and mainte nance with 50 mg/kg i.p. pentobarbital. Atropine methyl nitrate (0.18 mg/kg i.p.) was given as premedication to prevent airway obstruction by mucus formation. Animals were allowed to breath spontaneously. Rectal temperature was maintained at 37°C by a thermostatically regulated heating pad. A PE-50 catheter was introduced into the right femoral artery for continuous monitoring of MABP, as well as for repeated sampling of blood for serial measure ments of arterial oxygen (P a02) , carbon dioxide (P aC02) , pH (ABL 30 Acid-Base Analyzer, Radiometer, Copenhagen, Denmark) hematocrit, and blood glucose. Under the oper ating microscope, the right common carotid artery (CCA) was exposed through a ventral midline incision, and the external carotid artery (ECA) and internal carotid artery (lCA) isolated. The CCA was tied at -8 mm from the bifurcation. The ECA was tied at -5 mm from the bifurca tion (permanent double knot), and a second loose knot was placed around the ECA origin. After placing a micro vascular clip across the ICA adjacent to the ECA origin, a partial incision was made in the ECA midway between the permanent double knot and second loose knot. A 3-0 monofilament nylon suture with rounded tip was intro duced into the ECA lumen, the ECA stump was tightened around the intraluminal nylon suture to prevent bleeding, and the microvascular clip removed. The nylon suture was then gently advanced from the ECA into the ICA lumen, and thc tip advanced 17.5 mm from the bifurcation to occlude the MCA at its origin from the circle of Willis.
After 1 h of occlusion, the thread was pulled out, the ECA permanently tied at the level of bifurcation, and the CCA opened to allow reperfusion.
Blood flow and head temperature measurements 
Neurologic examination
Neurologic examination (n = 12/group) was performed 24 h after reperfusion, just prior to killing. Neurologic out come was scored on a six-point scale, as described (Kittaka et aI., 1996) : a score of 0 indicated no neurologic deficit (normal); a score of 1 (failure to extend left forepaw fully) indicated a mild focal neurologic deficit; a score of 2 (cir cling to the left) indicated a moderate focal neurologic deficit; and a score of 3 (falling to the left) indicated a severe focal deficit. Rats with score 4 did not walk spontane ously and had a depressed level of consciousness; a score of 5 was stroke-related death (not observed in the pres ent study). 100% of rats were affected, the infarct area in which 2:50% of rats were affected, and the infarct area in which <50% of rats were affected.
Measur�ment of volume of injury

Isolation of brain capillaries
Brain capillaries were isolated from nicotine-treated (n = 12) and control (n = 12) rats using a modified mechani cal homogenization technique (Zlokovic et aI., 1993) .
Briefly, brains were immediately removed from the skull and immersed in ice-cold buffer B (103 mM NaC!, 4.7 mM KCl, 2.5 mM CaCh, 1.2 mM KH2P04, 1.2 mM MgS04, and 15 mM HEPES, pH, 7.4). The cerebral cortical mantles were rapidly freed of meninges (i.e., pial vessels); the arter ies of the circle of Willis, veins, and choroid plexi were discarded; and cerebral cortices were used to isolate the capillaries. Brain homogenization in buffer A (buffer B + 25 mM HC0 3 , 10 mM glucose, 1 mM sodium pyruvate, and 1 g/lOO ml dextran, molecular mobility (Mr) = 64,000), using a hand-held Teflon homogenizer, was followed by dextran density centrifugation at 5,800 X g at 4°C. The pellet was resuspended in buffer A and passed over a 85 /Lm nylon mesh. Arterioles and venules remained on top of the mesh, while capillaries, red cells, nuclei, and other debris were collected in the filtrate passing through the mesh. This filtrate was then passed over a column con taining 3 X 4-cm glass beads (0.45-mm diameter) with 44-/Lm nylon mesh at the bottom, and the column washed with buffer B. Brain capillaries adhere to the glass beads while the other contaminants pass unimpeded. Capillaries were recovered by repeated gentle agitation of the glass beads in buffer A, and the supernatant with capillaries was decanted and spun at 500 X g for 5 min to obtain the final pellet. The purity of the cerebral capillary preparation was checked by light and phase microscopy. The cerebral capil laries were free of adjoining brain tissue, and preparations consisted primarily of capillaries, but also contained minor amounts (5-10%) of small arterioles, as described (Zlo kovic et aI., 1993; Zlokovic et aI., 1995b) . Capillary-depleted brain homogenates were centrifuged a second time at 5,800 X g at 4°C to obtain a final capillary-free brain supernatant.
The presence of no more than minimal detectable activity of a specific cerebrovascular marker, y-glutamyl transpepti dase, was used to confirm the absence of contamination of capillary-depleted brains with microvessels, but not to demonstrate that the microvascular preparations were cap illaries only. A more detailed description of the capillary isolation procedure and the capillary (microvessels) prepa ration, as well as possible pitfalls in data interpretation, may be found elsewhere (Joo, 1993; Zlokovic, 1993) .
Western blot analysis
Brain capillaries and capillary-depleted brains from nico tine-treated and control rats were homogenzied using a motor-driven Potter-Elvehjem teflon homogenizer in a buffer containing 5% sorbitol, 5 mM histidine, 25 mM imid azole, 1 mM EDT A at pH 7.5 with inclusion of proteolytic enzyme inhibitors, 0.5 mM phenylmethylsulfonyl fluoride, 1 /Lg/ml leupeptin, and 1 mM amino-benzamidine dihy drocloride, as reported (Zlokovic et aI., 1993; Zlokovic e t aI., 1995b) . A rabbit polyclonal anti-mouse t-PA IgG frac tion that detects t-PA only, and not PAI-l complexes (Seeds et aI., 1995; Zlokovic et aI., 1995b) was obtained from Dr. N. Seeds. The specificity of this t-PA antibody was confirmed previously in our laboratory on Western blots containing conditioned medium from developing mouse cerebellar cells, which actively secrete t-PA, 1 ng human melanoma t-PA (World Health Organization inter national standard), and rat kidney extracts rich in t-PA (Seeds et ai., 1995; Ziokovic et ai., 1995b; Kittaka et ai., 1996) . Pre absorption of this t-PA antibody with mouse t PA resulted in loss of immunoreactivity in t-PA-rich kidney tissue, and abolished detection of the material on Western blots (Seeds et ai., 1995; Ziokovic et ai., 1995b) . A rabbit polyclonal anti-rat PAl -1 IgG fraction that immunoprecipi tates PAI-l and PAI-l-t-PA complexes was obtained from American Diagnostic Inc. (Greenwich, CT, U.S.A.) (prod uct no. 1062). Gels were blotted onto diazotized paper and incubated overnight with polyclonal anti-t-PA (1 : 600 dilution) and anti-PAI-l (1 : 200 dilution) antibodies. The enhanced chemiluminescence Western blotting detcction system (Amersham, Arlington Heights, IL, U.S.A.) was used to detect t-PA and expose it to hyperfilm. Migration of t-PA, PAl-I, and PAI-l-t-PA complexes from tissue samples was compared with the relative mobilities of mo lecular weight standards run on the same gel. Chemillumi grams were scanned with a Hoefer GS 300 scanning densi tometer. Each sample was analyzed at least two times and each lane was scanned three times. The linearity of the system for studied antigens (stan. dard curves) was demon strated to be 1-10 J.Lg of total capillary proteins for t-PA (Zlokovic et aI. , 1995b) , as well as for the PAI-1 antigen and PAI-1-t-PA complexes (not shown).
Reverse transcription (RT)-polymerase chain reaction (PC\l.) analysis
Total RNA (�4 J.Lg) was extracted with guanidium iso thiocyanate from pooled capillary samples obtained from either four nicotine-treated or four control rats, and from capillary-depleted brains (Chomoczynski and Sacchi, 1987) . This experiment was repeated three times (n = 121 group). The RNA was reverse transcribed using 1 J.Lg oligo 
Statistical analysis
Physiological variables, infarction, and edema volumes were compared between groups using Student's t-test. Non parametric data (neurologic outcome scores) were sub jected to the Kruskal-Wallis test. A p < 0.05 was considered statistically significant.
RESULTS
Physiologic variables
In nicotine-treated rats, plasma levels of nicotine and cotinine were significantly elevated after 14 days of treatment (Table 1 ). Nicotine and cotinine were undetectable in the control group. There was no sig nificant difference in body weight between experi mental and control groups, as previously observed with this dosage regimen (Murrin et ai., 1987) . No difference in physiologic variables (including tempo ralis muscle temperature) were noted between nico tine and control groups before MCA occlusion, dur ing occlusion, or during reperfusion (Table 2) . Figure 1 illustrates changes in CBF during MCA occlusion and reperfusion. No significant difference in baseline tissue perfusion units were observed be tween nicotine and control rats, indicating similar preocclusion CBF values. Reductions in CBF during occlusion were comparable between the two groups, i.e., 17-19% (p < 0.001) and 15-16% (p < 0.001) of baseline in the ischemic core of control and nicotine treated rats, respectively, and 34-37% (p < 0.001) and 31-35% (p < 0.001) of baseline in the periphery of the ischemic core of control and nicotine-treated rats, respectively. The trend towards CBF restoration during reperfusion was significantly impaired in the periphery of the ischemic core of nicotine-treated rats, and an increase from 60 to 65% (p < 0.01) of baseline was recorded 10-60 min of reperfusion. In contrast, during the same period of reperfusion, the CBF in control rats rose from 77 to 86%. In the ischemic core of both control and nicotine-treated rats, CBF was restored to �50% (p < 0.001) of preoc clusion values.
Neurologic outcome
There was a marked difference in outcome be tween control and nicotine-treated rats (Table 3 ). In the control group, five of 12 rats had no neurologic Data are mean ± SE (n = 18). Rats were administered nicotine tartrate (4.5 mg/kg of nicotine-free base/day). Values are mean:+: SO, n = 12 for control and nicotine-treated group. Preocclusion, 10 min prior to MCA occlusion. MCA occlusion, data at 10, 30, and 60 min (except for T) were pooled since there was no significant difference at different time points. Reperfusion, data at 10 and 60 min (except for T) were pooled since there was no significant difference. Data for T were 10 min prior and 60 min after MeA occlusion, and 60 min after reperfusion. MABP, mean arterial hlood pressure; T, temporalis muscle temperature.
symptoms, in contrast to the nicotine-treated group, in which 10 of 12 rats had some neurologic deficit. A typical score of 2 was found in 50% of nicotine treated rats, and only in one of 12 control rats. A severe focal neurologic deficit (scores 3 and 4) was observed in two nicotine-treated rats and in none of the control rats.
Neuropathology
Total volume of injury corrected for edema volume was significantly increased in the nicotine group by 21 % relative to that in control rats (Table 4) . Total edema volume was also increased in nicotine-treated rats by 110%. These increases were caused by signifi cant increases in injury volume (36%, p < 0.05) and Reperfusion Time (min) edema volume (121 %, P < 0.02) in the pallium indi cating expansion of injury into cortical regions. Injury volume in the striatum was not affected by nicotine, while there was a significant 83% increase in edema volume. Variability of injury volume was larger in the nicotine-treated group. Total area of brain injury, determined at the level of the optic chiasm (anterior coronal block) and expressed as a percentage of the coronal sectional area, was increased in nicotine treated rats by 35% compared to a 38% increase in brain injury expressed as a percentage of the total hemispheric volume. Figure 2 illustrates that 100% of control rats had the injury only in the lateral striatum; 2:50% exhibited changes in dorsolateral, lat eral, and ventrolateral cortexes, and <50% showed changes in the medial cortex and striatum. All nico tine-treated rats exhibited changes in the dorsolat eral, lateral, and ventrolateral cortexes.
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Expression of t-PA and PAI-l
After 14 days, the presence of a single t -P A band of �67 kDa was detected only in brain capillaries of control rats (n = 9), and the t-PA signal was absent from capillaries of nicotine-treated (n = 9) rats (Fig.  3A) . Complete depletion of t-PA antigen was found in all studied nicotine-treated rats. In both groups, the t-PA signal was absent from capillary-depleted brains (data not shown), as previously demonstrated (Zlokovic et aI., 1995b) . Omission of primary anti-t PA antibodies resulted in loss of t-PA signal (data not shown); preincubation of this anti-t-PA antibody with immobilized t -P A on Affigel beads resulted in loss of immun b reactivity in t-PA-rich tissues, such as kidney glomeruli, and abolished detection of the material on Western blots (data not shown), as pre viously reported (Seeds et aI., 1995; Zlokovic et aI., 1995b) . The PAI-l antigen (45 kDa) and PAI-l-t PA complexes (�1l0 kDa) were detected in both control (n = 6) and nicotine-treated (n = 6) rats (Fig.  3B) . In contrast to t-PA antigen, there was no change in the PAl -1 antigen in brain capillaries of nicotine treated rats, and only a minimal (6%) decrease in PAI-l-t-PA complexes was found as a result of nico tine treatment. Results of scanning densitometry of t-PA, PAl-I, and PAI-l-t-PA complex immunoblots are shown in Fig. 3C .
RT-PCR analysis revealed the presence of t-PA cDNA in samples derived from brain capillaries of both control and nicotine-treated rats (Fig. 4A) . Scanning densitometry results indicated that the rela tive abundance of t-PA mRNA in the two groups (n = 12/group, i.e., 3 X 4 pooled samples/group) was comparable, using ,B-actin as a control (Fig. 4B) . As indicated in the methods section, RT-PCR analysis showed relative changes in t-PA expression with re spect to a housekeeping gene. In preliminary studies, the number of cycles varied and there was a direct relationship between cycle number, up to 35, and band intensity. Thus, the number of cycles used in the present study (n = 30) was within the linear range of the amplification response. Following RT-PCR,,B actin band density was similar in capillary samples from control and nicotine-treated rats. All capillary depleted brains in both groups exhibited minimal or no expression of t-PA mRNA (data not shown).
DISCUSSION
The present study demonstrates that chronic nico tine administration in rats that approximates the amount of nicotine intake via cigarette smoking in humans, equivalent to �2-3 pack/day (Murrin et aI., 1987) , results in impaired restoration of blood flow following reversible MCA occlusion, poor neurologic outcome, and enhanced focal ischemic brain injury in comparison to control rats. We confirmed that both t-PA antigen and t-PA mRNA remain displayed in microvessels isolated from rodent brain (Zlokovic et aI., 1995b; Kittaka et aI., 1996) , and that PAI-l anti gen and PAI-l-t-PA complexes in cerebral microves sels can also be demonstrated. These findings suggest that the rat may be a suitable model in which to study changes within the cerebromicrovascular t-PA/PAI-1 system in vivo in relation to ischemic stroke. Nota bly, the effect of nicotine on focal ischemic stroke was associated with complete depletion of the free pool of brain capillary t -P A antigen in chronically treated rats, whie PAI-l antigen and PAI-l-t-PA complexes remained unaffected by this treatment. In vitro studies have demonstrated that produc tion, release, and synthesis of t -P A and its rapid inhib itor P AI-1 in systemic endothelial cells is regulated by various physiologic and pathologic stimuli. For example, coordinated induction of both t-PA and PAI-1 has been reported with thrombin or basic fi broblast growth factor, while histamine, activated protein C, and phorbol ester induce t-PA alone, and lipopolysaccharide (LPS), transforming growth factor-p, interleukin-1 (IL-1 Relative abundance of t-PA (n = 9/group) and PAI-1 antigens (n = 6/ group) and PAI-1-t-PA complex (n = 6/group) in control and nicotine-treated rats, determined by scanning densitometry. Val ues in each of the control groups are arbitrarily taken as 1. ing results of PCR amplification using t-PA primers that corre spond to nucleotides 699-727 (sense) and 1,540-1,568 (anti sense) of the published sequence of rat t-PA. Cerebral capillaries from two control groups (n = 4 for a pooled sample/group, lanes 1 and 5) and two nkotine-treated groups (n = 4 for a pooled sample/group, lanes 2 and 6) rats. As a control for nonchanging gene expression, the amplification, using {3-actin primers in control (lanes 3 and 7) and nicotine-treated (lanes 4 and 8) rats, is shown. 1987; Saksela et aI., 1987; Sakata et aI., 1985; Levin and Santell, 1988; Schleef et aI., 1988; Emeis and Koistra, 1986; Sawdey et aI., 1989) . It has been shown that human systemic endothelial cells in vitro secrete more t-PA when exposed to arterial levels of shear stress (Diamond et aI., 1989) and pulsatile stretch (Iba et a1., 1991) , while PAI-l secretion remains unaf fected. It has been also demonstrated that t-PA secre tion and t-PA mRNA are significantly up-regulated with serial passages in culture, while the urokinase type plasminogen activator gene that is normally not expressed in primary culture, becomes quite active at higher passage numbers (reviewed in Iba et aI., 1991) . These studies suggest that the expression of each of the two antigens may be regulated indepen dently by various chemical or mechanical stimuli, and that under in vitro conditions their expression may be enhanced and/or modulated as a reaction to the tissue culture environment. In vivo studies in non-human primates, in contrast to in vitro studies, suggest that TNF-a plays a pivotal role in the release of both t-PA and PAI-l antigens during LPS (endotoxin) stimulation (Biemond et aI., 1995) . Release of both t-PA and PAI-l by LPS in vivo has also been reported in rats (Emeis et aI., 1995) . In vivo studies in rats in contrast to in vivo studies in nonhuman primates indicated that neither TNF-a nor IL-l are significantly involved in the in duction of PAI-l by LPS (Emeis et a1., 1995) . Among other differences, expression of t-PA in cerebral mi crovessels in nonhuman primates in vivo has been found to be limited to some precapillary arterioles and postcapillary venules (Levin and del Zoppo, 1994) , while in rats and guinea-pigs, t-PA antigen is expressed in cerebral capillaries in vivo (Zlokovic et aI., 1995b) . It has also been shown recently that regulation of t-PA and PAI-l in rat aorta in response to LPS differs from that observed in mouse aorta and rat carotid artery (Padro et aI., 1994) . Thus, taken together, these studies caution against extrapolation of results and conclusions from one tissue or species subjected to specific types of stimuli to another, as well as from the in vitro setting to an in vivo situation. The present study demonstrates that chronic nico tine administration depletes brain capillary t-PA anti gen in vivo, while the relative abundance of PAI-l antigen and PAI-l-t-PA complexes is unaffected by this treatment. These results suggest that nicotine could significantly reduce "local" fibrinolytic poten tial in brain microcirculation by completely depleting the free pool of microvascular t-P A. The only t-PA that was found in brain capillaries of nicotine-treated rats remained bound to PAl-I, and therefore, is likely to be functionally inactive. The unchanged level of cerbromicrovascular PAI-l antigen suggests that at this stage of chronic nicotine treatment (14 days), PAI-l most likely is not involved in reducing the level of t -P A antigen. The absence of increased amounts of PAI-l-t-PA complexes in the microvasculature of nicotine-treated rats supports this hypothesis.
In vitro studies in bovine aortic endothelial cells have shown that acute nicotine exposure is associated with direct pharmacological stimulation of t-PA se cretion (Kuo et aI., 1989) . It has been also shown that acute smoking transiently elevates plasma t-PA antigen, either via the direct effect of nicotine, ele vated vasopressin level, and/or elevated catechola mines (as a secondary nicotine effect), all of which release endothelial t-PA (Allen et aI., 1985) . In con trast, chronic exposure to tobacco smoke and nicotine diminishes fibrinolytic activity, reduces levels of t P A antigen in plasma and peripheral vascular vessel walls, and decreases t-PA release following stimula tion with vasopressin (Allen et aI., 1985; Kjaelgaard and Larsson, 1986; Haire et ai., 1989; Ozdemir et ai., 1992) .
The mechanism of t -P A antigen depletion in brain microvessels by nicotine is presently not understood. The relative abundance of t-PA mRNA versus {3-actin mRNA in cerebral microvessels of nicotine treated rats remains unchanged in comparison to that in control vehicle-treated rats. Although absolute changes in t-PA mRNA expression were not deter mined in the present study, it is likely that alterations in transcriptional activity or mRNA stability would be reflected by differences in band intensity following semiquantitative RT-PCR. Thus, the results suggest that the effect of nicotine is mediated at the posttran scriptional levei. There are many possible explana tions for the dissociation between t-PA mRNA and protein, including posttranslational modifications that result in altered t-PA turnover, and release, se cretion, or antibody recognition. Variations in pro tein levels in the face of unchanging mRNA levels are well documented (e.g., Hengst and Reed, 1996) . A discrepancy between t-PA mRNA and t-PA anti gen changes has also been reported for the adventitia of rat aorta, in which an increase in t-PA mRNA after LPS treatment was unaccompanied by a change in the le r el of t-PA antigen (Padro et ai., 1994) .
In vitro studies with systemic endothelial cells have demonstrated that environmental stress may influ ence t-PA gene expression independently of PAI-1 gene expression (Diamond et ai., 1989; Iba et ai., 1991) . It has been suggested that morphological changes in endothelial cells (i.e., cytoskeletal re arrangement, increase in monolayer permeability, cellular shape change) in response to stress (i.e., shear, stretch, generation of oxygen radicals, hyperto nicity) correlate well with stress-stimulated t-PA mRNA production (reviewed in Levin et ai., 1993) . Ultrastructural analysis of brain microvasculature in the present nicotine model in rodents failed to dem onstrate any morphological changes in brain endo thelial cells in vivo, as reported for guinea-pigs (Bar ron et ai., 1992) and 14-day treated rats (data not shown). This is in contrast to giant cell formation of aortic endothelial cells in vitro in response to nicotine (Talloss and Booyse, 1978) , ruffled membranes, and extensive cellular vacuolation of rabbit aortic endo thelium following oral consumption of nicotine (Booyse et ai., 1981) , and mitochondrial swelling in the aortic endothelium in mouse in vivo (Zimmerman and McGeachie, 1987) . Lack of ultrastructural alter ations in brain endothelial cells in guinea pigs and rats may reflect either subthreshold exposure to nicotine, different response of these cells to the toxin, and/or species differences.
The present study demonstrates a 21 % increase in the injury volume of the gray matter corrected for edema in nicotine-treated versus control rats. This increase was caused by expansion of injury into the cortical regions; increase in the injury size in the pallium was 36%. No significant change in cortical CBF was observed in nicotine-treated rats prior to MCA occlusion. However, whether the reactivity of vessels to CO2 during reperfusion is altered by nico tine treatment -and, thus, the status of vascular nitric oxide synthase that normally may be protective after MCA occlusion in mice (Huang et ai., 1994) -are presently unknown. Vasospastic effects of nicotine patches followed by stroke have been reported in chronic smokers (Jackson, 1993) . Our earlier work showed that chronic nicotine treatment in rats spe cifically down-regulates the (X2 subunit of the sodium pump in cerebral microvessels and neuron-associated glia (Zlokovic et ai., 1993; Wang et ai., 1994) . It is possible that because of impaired NA,K-ATPase function after MCA occlusion (Yang et ai., 1992) , nicotine-treated rats may become more prone to de velop postischemic cellular brain edema and micro vascular luminal narrowing that could impair CBF during reperfusion. In experimental models of thromboembolic stroke (Gross et aI., 1995) and MCA occlusion (Nakajima et aI., 1993) , thrombolytic therapy with exogenous t P A administered within the therapeutic window re duced the size of infarction and edema, and partially restored CBF (Gross et ai., 1995) . Using a model of reversible MCA occlusion, the present study demon strated that depletion of endogenous brain capillary t-PA antigen in nicotine-treated rats correlates well with diminished restoration of CBF during reperfu sion, poor neurologic outcome, and larger volumes of brain infarction and edema in comparison to con trol rats. During reperfusion, nicotine-treated rats exhibited a trend toward impaired CBF restoration in the periphery of the ischemic region, perhaps due to normal endogenous microvascular thrombolysis, although other multiple possible effects of nicotine on neurons and the microvasculature may also be involved. This might be similar to the recently re ported association between depleted cerebromicro vascular t-PA antigen and focal ischemic brain injury in a diabetic model in rats (Kittaka et ai., 1996) .
It is not certain whether nicotine effects in habitual smokers are comparable to results of this study. Inter mittent bolus-like dosing of nicotine from cigarettes could have different effects from those produced by' the continually released transdermal nicotine of patches and/or the continuous chronic s.c. adminis tration of nicotine via minipumps, as in this study. However, an association between depletion of t-PA antigen from coronary vessels and subsequent devel-opment of coronary artery disease in patients has been reported (Lasarsere et aI., 1995) , and it is possi ble that depletion of the free t -P A antigen pool within the brain microcirculation may compromise brain fi brinolytic capacity in smokers, predisposing to larger and more disabling strokes. On the other hand, it might be that direct acute effects of nicotine (i.e., within several hours) on t-PA mRNA and antigen expression in brain endothelial cells in vitro may be different from chronic in vivo effects as in this study (i.e., over a 2-week exposure).
It is well established that free radical production plays a role in brain injury in reperfusion models (Siesjo, 1992) . It has been shown that acute exposure to nicotine increases formation of reactive oxygen species in epithelial tissues (Wetsher et aI., 1995a; Wetsher et aI., 1995b) , but whether chronic nicotine administration results in free radical production in brain in vivo has not been investigated. Thus, the possibility that the effect of nicotine on brain injury is due to both vascular and neuronal effects should be considered, and, in particular, in relation to vascular changes in t-P A expression, as suggested by the pres ent study, and the possible role of t-PA in neuronal degeneration induced by excitotoxins (Tsirka et aI., 1995) , such as nicotine. (
